Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade
Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that activation of...
Saved in:
Published in | BMC cancer Vol. 13; no. 1; p. 327 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
03.07.2013
BioMed Central |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2407 1471-2407 |
DOI | 10.1186/1471-2407-13-327 |
Cover
Loading…